-
Amgen Inc. (AMGN)
-
Intuitive Surgical Inc. (ISRG)
-
Eli Lilly and Company (LLY)
-
WELL Health Technologies Corp. (WELL)
Q: WELL was $3.50 in August 2020 and its $3.55 today.
Reminds me a lot of GUD. IMHO 5i tends to be overly patient on some failed investments whereby selling them and moving on could make for a much better return.
So I have been as patient as I want to be with WELL. When I sell my shares of WELL, which I intend to do, what would be a good replacement that is well managed and has good potential growth in its future outlook?
And of course, has a proven management team.
Thanks
Sheldon
Reminds me a lot of GUD. IMHO 5i tends to be overly patient on some failed investments whereby selling them and moving on could make for a much better return.
So I have been as patient as I want to be with WELL. When I sell my shares of WELL, which I intend to do, what would be a good replacement that is well managed and has good potential growth in its future outlook?
And of course, has a proven management team.
Thanks
Sheldon
5i Research Answer:
We do have patience if the fundamentals justify it. In 2020, WELL had $50M in revenue. This year's forecast is for close to $1B. In 2020 WELL had a loss of 3 cents per share. 2024E calls for 22c per share in earnings. If comparing to GUD, its comparable growth in the same period was not even close. VHI is one potential alternative. It is not a direct healthcare play but serves the industry. Otherwise, we would move to the US with LLY or AMGN or ISRG.